Conference abstractPublished 13 Sep 2017

Are incretins promoters or initiators of pancreatic cancer?

Authors: Parviz M Pour

University of Nebraska Medical Center, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Recently, striking abnormalities in the insulin-ductuar cells of pancreas were reported in Type-2 diabetic patients treated with GLP-1-1 analog. Our studies revealed that these alterations were almost identical to the early neoplastic changes that occur in the hamster pancreatic cancer model. To confirm these similarities, we examined the pancreas of a Type-2 diabetic patient, who developed pancreatic cancer a year after the treatment with GLP-1 analogs. As in the hamster model, there were multifocal proliferation of insulin-ductular cells with atria and patterns consistent with in-situ carcinomas. The relevance of these findings and possible biological pathways will be discussed.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.

Try:

More from this journal

The newest in Pancreatic Disorders & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPancreatic Disorders & Therapy
  • SubjectGastroenterology & Hepatology
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Parviz M Pour”